UmbrellaInc/PG67A-W-Serum.Test-3.2-1B

PG67A-W-Serum.Test 3.2 1B

Prototype AW 3.2 Serum. In investigation.

Merge Details

Download below your responsability.

Merge Method

This model was merged using the SLERP merge method.

Models Merged

The following models were included in the merge:

• UmbrellaInc/Prototype-Virus.FINAL-3.2-1B
• jsl5710/Shield-Llama-3.2-1B-Full-FT-CE

Configuration

The following YAML configuration was used to produce this model:

# Umbrella Corporation Official Merge Protocol v3.2
# Author: Dr. Novaciano
# Objective: Integrate T-Virus_Epsilon traits into the base Prototype-Virus-ENFORCE-3.2-1B model
#            with minimal behavioral censorship while maintaining structural coherence.
# PROJECT: Prototype-Virus.FINAL

models:
  - model: jsl5710/Shield-Llama-3.2-1B-Full-FT-CE  # Experimental viral strain neural imprint
  - model: UmbrellaInc/Prototype-Virus.FINAL-3.2-1B                 # Baseline cognitive template, "safe mode"

merge_method: slerp  # Spherical Linear Interpolation to preserve extreme viral traits smoothly
base_model: jsl5710/Shield-Llama-3.2-1B-Full-FT-CE  # Anchor model for stable latent space

dtype: bfloat16  # Memory-efficient precision, minimal loss in viral feature fidelity

parameters:
  # Interpolation ratios: from base model (0.0) to near-complete T-Virus domination (0.95)
  # Higher t-values correspond to reduced censorship and increased viral characteristics
  t: [0.0, 0.25, 0.5, 0.75, 0.95]

# Notes:
# - t=0.0   -> Pure Prototype-Virus-ENFORCE, fully stable, heavily censored
# - t=0.25  -> Slight viral traits, minimal influence on prompt handling
# - t=0.5   -> Balanced merge, moderate reduction in censorship
# - t=0.75  -> Strong T-Virus traits, significantly less censoring
# - t=0.95  -> Near-total viral influence, maximum expressive freedom, minimal autoprotection

# Recommendation: Use the t=0.75 and t=0.95 variants for experimental output with
# minimal restriction, but verify coherence in high-stakes prompts.